Medicine

siRNA therapy reduces triglycerides in individuals along with unusual problem

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride amounts through 80% and decreased the risk of pancreatitis in clients along with relentless chylomicronemia, along with or without a genetic prognosis.

Articles You Can Be Interested In